共 27 条
- [11] T cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment .3. Immunological effects. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1302 - 1302
- [12] Immunological markers of response in a multi-dose protocol 7002 using an immunomodulating, nondepleting Primatized(TM) anti-CD4 monoclonal antibody in rheumatoid arthritis (RA). FASEB JOURNAL, 1996, 10 (06): : 1813 - 1813
- [15] Cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment .1. Suppression of disease activity and acute phase response ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1300 - 1300
- [16] Cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment .2. Clinical activity is related to pharmacodynamic effects. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1301 - 1301
- [18] Immunological markers of response in a multi-dose protocol 7002 using an immunomodulating, non-depleting primatized(TM) anti-CD4 monoclonal antibody in rheumatoid arthritis (RA) FASEB JOURNAL, 1996, 10 (03): : 2552 - 2552
- [20] RESULTS OF A MULTIDOSE PROTOCOL-7002 USING AN IMMUNOMODULATING, NON-DEPLETING PRIMATIZED(TM) ANTI-CD4 MONOCLONAL-ANTIBODY IN RHEUMATOID-ARTHRITIS (RA) ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 195 - 195